Deutsche Bank Securities Inc., UBS Investment Bank, BNP Paribas Securities Corp., Citizens Bank, N.A., Truist Securities and Wells Fargo served as financial advisors to Gentiva while Houlihan Lokey ...

Sanofi and CD&R enter exclusive talks to sell a 50% stake in Opella, Sanofi's consumer health unit, valued at $17.4 billion. Opella serves over 500M consumers globally with top brands like Allegra and ...

PARIS (Reuters) -Sanofi has entered into talks to sell a controlling 50% stake in its consumer health business Opella to U.S. private equity firm Clayton Dubilier & Rice, the French pharmaceutical ...

Sanofi and CD&R are joining forces to fuel Opella’s ambitions as a French-headquartered, global consumer healthcare champion. Sanofi and CD&R have entered exclusive negotiations for the potential sale ...

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today announced that it has successfully completed its previously-announced transaction with private investment firm Clayton, Dubilier & Rice ...

France-based Sanofi S.A. (FR:SAN) is exploring the sale of its stake in its Consumer Health unit to an American private equity firm CD&R (Clayton, Dubilier & Rice). Following a report by Reuters, the ...

Sanofi (NASDAQ:SNY) is close to a deal to sell its consumer health unit to private equity firm Clayton Dubilier & Rice for about €15 billion ($16.4 billion). A deal may be announced in the coming days ...

Home health care, a personalized alternative to institutional care, is becoming a critical pillar of modern medicine. As more individuals seek health solutions that prioritize dignity, independence, ...

If 2020 was the year of the great paradigm shift for virtual care, 2025 is shaping up to be the summer blockbuster sequel. H.R. 1, the big 870-page budget reconciliation legislation passed by Congress ...

Sanofi (NASDAQ:SNY) has entered a share purchase agreement in relation to the sale of a 50% controlling stake in Opella, its consumer healthcare business, to private equity firm CD&R. The terms of the ...